论文信息 - Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes - 字舞流文

Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes

M. Piccart | Z. Aziz | D. Fraser | L. Warren | L. Harris | A. Armour | J. Gralow | M. Andersson | L. Briley | J. Zujewski | M. Toi | A. Mehta | C. Spraggs | Z. Jiang | L. Williams | L. Parham | R. Crescenzo | J. Byrne | S. Ahmed | G. Demetriou | N. Jackson | E. Pérez | Martine Piccart | L. Warren | Z-f Jiang | Zeba Aziz | Ajay O. Mehta | Julie Byrne | Michael Andersson | Masakazu Toi | Lyndsay Harris | JoAnne Zujewski | M. Piccart